I am a New Orleans native currently residing in Baton Rouge. My academic background is in actuarial sciences and financial mathematics. I've worked for the Louisiana Biomedical Research Network for the past four years and as Research Administrator of Healthcare for the United Traders group ... more
I am a New Orleans native currently residing in Baton Rouge. My academic background is in actuarial sciences and financial mathematics. I've worked for the Louisiana Biomedical Research Network for the past four years and as Research Administrator of Healthcare for the United Traders group for two years. I also contribute to Seeking Alpha (https://seekingalpha.com/author/andrew-roberts/articles).
I am influenced largely by Benjamin Graham's teachings in "Security Analysis" and Peter Lynch's teachings in "One Up On Wall Street". My broad investment niche is the healthcare sector, with some specialty in the biotechnology and pharmaceuticals industries. I have learned to prioritize the business model in my evaluation. There are many businesses with exceptional operational histories; focus on the business model allows the investor to distinguish companies with economic moat from those which look good on paper but possess no staying power.
I'm been published on TalkMarkets and Seeking Alpha.
Premium Content Creator | |
Seeking Alpha | |
January 2018 - Present (5 years 1 month) | |
• Authored investment editorials covering Healthcare industry equities |
IT Student Assistant | |
Louisiana State University | |
February 2015 - March 2018 (3 years 2 months) | |
• Developed summer research applications with RedCAP software including use of SQL queries, HTML5, and branching logic for online survey implementation |
Financial Reporting Department Intern | |
Pan-American Life Insurance | |
May 2016 - August 2016 (4 months) | |
• Developed and tested MG-ALFA templates for DAC amortization K-factor testing |
Louisiana State University | |
BS | |
2014 / 2018 | |
Mathematics - Actuarial Science |
Latest Comments
Corcept Therapeutics: Discounted Biotech Company Offers Exceptional Risk Profile And Lucrative Proprietary Pipeline
Thanks for reading, Harry.
Corcept Therapeutics: Discounted Biotech Company Offers Exceptional Risk Profile And Lucrative Proprietary Pipeline
Thanks Walter!
Corcept Therapeutics: Discounted Biotech Company Offers Exceptional Risk Profile And Lucrative Proprietary Pipeline
Thanks for reading!